Idorsia Ltd. (SIX: IDIA) today announced a milestone in the development of its first bacterial vaccine based on the company's synthetic glycan chemistry platform. The Clostridioides difficile (C.

The Vaccine and Infectious Disease Organization (VIDO) at the University of Saskatchewan in Saskatoon is an internationally recognized, state-of-the-art centre for human and animal infectious disease ...

JOHANNESBURG (Reuters) -South African biopharmaceutical firm Biovac on Thursday opened a state-of-the-art product development laboratory in Cape Town, backed by the Gates Foundation, to help the ...

In the early 2000s, immunologist Bali Pulendran started his lab at Emory University to explore the mechanisms underlying vaccine-mediated immunity. To uncover these processes, he focused on the yellow ...

The National Vaccine Institute (NVI) has established an mRNA laboratory at the Noguchi Memorial Institute for Medical Research, making Ghana one of only five African countries with the cutting-edge ...

Hilleman Laboratories, a Singapore-based joint venture of Merck & Co. Inc. MSD division and Wellcome, said Thursday it will develop and manufacture clinical trial doses of an investigational ...

A University of Cambridge team has had a third success with its AI-guided technique for designing vaccines against highly ...

The National Vaccine Institute (NVI) has established a state-of-the-art mRNA laboratory at the Noguchi Memorial Institute for ...

Launched in 2021 in the thick of the covid pandemic, the Hyderabad-based startup has an ambitious pipeline of first-in-class ...

An exciting collaboration between the Ragon Institute and the Jameel Clinic at MIT has achieved a significant milestone in leveraging artificial intelligence (AI) to aid the development of T cell ...

A researcher works on coronavirus vaccine development at the Walter Reed Army Institute of Research in Silver Spring, Md., April 28, 2020. Researchers around the world are working at a feverish pace ...